← Back to all articles
PharmacologyPubMed VerifiedOpen Access

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca regulates adult neurogenesis in vitro and in vivo

Morales-Garcia JA, Calleja-Conde J, Lopez-Moreno JA, Alonso-Gil S, Sanz-SanCristobal M, Riba J, Perez-Castillo A

Translational Psychiatry (2020)

Preclinical / in vivo
Abstract

Showed DMT promotes neurogenesis both in vitro (neural progenitor cells) and in vivo (mouse hippocampus). DMT-treated mice showed improved performance in memory tasks. Suggests neuroplasticity as a therapeutic mechanism.

Citations180
Study TypePreclinical / in vivo
neurogenesisDMThippocampusneuroplasticitypreclinical
DOI: 10.1038/s41398-020-01011-0View on PubMed

Related Articles

Pharmacology

Psychoactive substances of natural origin: toxicological aspects, therapeutic properties and analysis in biological samples

Goncalves J, Luis A et al.

Molecules, 2021
Pharmacology

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I et al.

Archives of Toxicology, 2025
Pharmacology

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans

Wittayakarn N, Tan YM et al.

Toxicological Sciences, 2025
Pharmacology

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves C, Dos Santos RG et al.

Frontiers in Psychiatry, 2024